Chlorides

Y-mAbs Announces Update on Omburtamab for DIPG

Retrieved on: 
Friday, June 4, 2021
Chemical elements, Pediatric cancers, Chemistry, Physical sciences, Brain tumor, Chlorides, Radiopharmaceuticals, Medulloblastoma, Lutetium, Neuroblastoma, Blastoma

We are excited to share these results that significantly broaden the potential reach of omburtamab, which would be addressing a clear unmet medical need.

Key Points: 
  • We are excited to share these results that significantly broaden the potential reach of omburtamab, which would be addressing a clear unmet medical need.
  • The results pave the way for our multicenter phase 2 study in DIPG later this year, where we expect to give up to three repeated doses of omburtamab, stated Thomas Gad, founder, Chairman and President.
  • Dr. Claus Moller, Chief Executive Officer, continued, We are expanding our omburtamab franchise significantly this year.
  • While the iodine labeled omburtamab targets DIPG, CNS/LM from neuroblastoma and DSRCT, we have also initiated clinical trials for medulloblastoma and B7-H3 positive CNS metastasis with our lutetium labeled omburtamab.

Monopar and NorthStar Announce Patent Filing on Promising Radiopharmaceutical Discovery

Retrieved on: 
Monday, May 24, 2021
Physical sciences, Chemistry, Chemical elements, Radiopharmaceuticals, Medicinal radiochemistry, Medicinal chemistry, Chlorides, Radiation therapy, Radiopharmacology, Actinium(III) iodide, Actinium(III) chloride, Provisional application

WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional patent with the U.S. Patent and Trademark Office (USPTO) titled Bio-Targeted Radiopharmaceutical Compositions Containing Ac-225 and Methods of Preparation.

Key Points: 
  • WILMETTE, Ill. and BELOIT, Wis., May 24, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) and NorthStar Medical Radioisotopes, LLC, today announced the filing of a provisional patent with the U.S. Patent and Trademark Office (USPTO) titled Bio-Targeted Radiopharmaceutical Compositions Containing Ac-225 and Methods of Preparation.
  • Radiopharmaceutical therapy is a promising approach to treat cancer and other diseases using radioactive metals bound with proteins/antibodies to target and kill cells.
  • If validated through further evaluation, it could potentially improve efficacy and safety and enhance manufacturing efficiency of Actinium-based radiopharmaceuticals.
  • Monopar and NorthStar plan to explore both internal development and out-licensing opportunities of this promising approach in Actinium-based radiopharmaceuticals.

NorthWest Copper Expands Stardust Cu-Au-Ag Deposit With New Resource Estimate

Retrieved on: 
Monday, May 17, 2021
Chemistry, Physical sciences, Natural sciences, Chlorides, Metal halides, Pyrotechnic colorants, Copper

Six separate mineral domain models were created in Leapfrog Geo to constrain the estimate.

Key Points: 
  • Six separate mineral domain models were created in Leapfrog Geo to constrain the estimate.
  • For the zone 2 domain, gold was capped at 15 g/t, silver at 140 g/t and copper at 7.5%.
  • With a robust portfolio in a tier one jurisdiction, NorthWest Copper is well positioned to participate fully in a strengthening global copper market.
  • NorthWest Copper does not undertake any obligation to update forward-looking statements except as required by applicable securities laws.

Global Tetrabutylammonium Chloride (CAS 1112-67-0) Market Research Report 2021 - Downstream Industry Trends - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 11, 2021
Chemicals, Plastics, Manufacturing, Chemistry, Physical sciences, Chemical compounds, Chlorides, Tetrabutylammonium chloride, Tetrabutylammonium, Chloride, Lithium, Ammonium chloride

b'The "Tetrabutylammonium chloride (CAS 1112-67-0) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis global report is a result of industry experts\' diligent work on researching the world market of Tetrabutylammonium chloride.

Key Points: 
  • b'The "Tetrabutylammonium chloride (CAS 1112-67-0) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com\'s offering.\nThis global report is a result of industry experts\' diligent work on researching the world market of Tetrabutylammonium chloride.
  • The report helps to build up a clear view of the market trends and development, identify major players in the industry, and estimate main downstream sectors.\nThe Tetrabutylammonium chloride global market report key points:\nThe first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).
  • The fifth chapter deals with Tetrabutylammonium chloride market trends and forecast, distinguish Tetrabutylammonium chloride manufacturers and suppliers.
  • The seventh chapter analyses Tetrabutylammonium chloride downstream markets.\n'

Intrepid Announces Date for First Quarter 2021 Earnings Release

Retrieved on: 
Monday, April 26, 2021
Chemistry, Physical sciences, Natural sciences, Dietary minerals, Food additives, Chlorides, Metal halides, Chemical elements, Potash, Fertilizer, Magnesium chloride, Potassium, Chemistry, Physical sciences, Natural sciences, Dietary minerals, Food additives, Chlorides, Metal halides, Chemical elements, Potash, Fertilizer, Magnesium chloride, Potassium

Intrepid is the only U.S. producer of muriate of potash, which is applied as an essential nutrient for healthy crop development, utilized in several industrial applications and used as an ingredient in animal feed.

Key Points: 
  • Intrepid is the only U.S. producer of muriate of potash, which is applied as an essential nutrient for healthy crop development, utilized in several industrial applications and used as an ingredient in animal feed.
  • In addition, Intrepid produces a specialty fertilizer, Trio\xc2\xae, which delivers three key nutrients, potassium, magnesium, and sulfate, in a single particle.
  • Intrepid also provides water, magnesium chloride, brine and various oilfield services.\nIntrepid serves diverse customers in markets where a logistical advantage exists and is a leader in the use of solar evaporation for potash production, resulting in lower cost and more environmentally friendly production.
  • Investors and other interested parties are encouraged to enroll at intrepidpotash.com , to receive automatic email alerts or RSS feeds for new postings.\n"

Nexus Pharmaceuticals Announces Launch of Succinylcholine Chloride Injection, USP

Retrieved on: 
Monday, April 12, 2021
Biotechnology, Pharmaceutical, Health, Medical Supplies, Chemical compounds, Drugs, Chlorides, Muscle relaxants, Quaternary ammonium compounds, Neuromuscular blockers, Suxamethonium chloride, Organ systems, Succinylcholine Chloride Injection, USP, Nexus Pharmaceuticals Inc.

b"Nexus Pharmaceuticals announced the launch of Succinylcholine Chloride Injection, USP in 200mg/10mL Multiple-Dose Vials.

Key Points: 
  • b"Nexus Pharmaceuticals announced the launch of Succinylcholine Chloride Injection, USP in 200mg/10mL Multiple-Dose Vials.
  • View the full release here: https://www.businesswire.com/news/home/20210412005426/en/\nNexus Pharmaceuticals Succinylcholine Chloride Injection, USP (Photo: Business Wire)\n\xe2\x80\x9cThe launch of Succinylcholine Chloride represents Nexus Pharmaceuticals\xe2\x80\x99 ability to supply critical products and to help fortify the supply chain,\xe2\x80\x9d said Shahid Ahmed, Chief Scientific Officer of Nexus Pharmaceuticals.
  • \xe2\x80\x9cThe COVID-19 pandemic deeply disrupted the supply of Succinylcholine Chloride, but Nexus\xe2\x80\x99 entry into the market will help alleviate constraints and provide peace of mind for our clinical partners.\xe2\x80\x9d\nNexus Pharmaceuticals\xe2\x80\x99 Succinylcholine Chloride Injection is available in cartons of 25 vials.\nSuccinylcholine Chloride Injection, USP is a sterile, nonpyrogenic solution to be used as an ultra-short-acting, depolarizing, skeletal muscle relaxant.
  • Nexus ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable life-saving treatment options when and where they\xe2\x80\x99re needed most.

Insights on the Benzalkonium Chloride Global Market to 2030 - by Type, Application, End-use Industry and Geography

Retrieved on: 
Wednesday, March 31, 2021
Chemical compounds, Cationic surfactants, Quaternary ammonium compounds, Chemistry, Antiseptics, Chlorides, Benzyl compounds, Materials, Benzalkonium chloride, Polyvinyl chloride

DUBLIN, March 31, 2021 /PRNewswire/ -- The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 31, 2021 /PRNewswire/ -- The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • This is expected to be the key factor to take the global benzalkonium chloride market to $1,301.1 million by 2030 from $525.0 million in 2019, at a 9.6% CAGR between 2020 and 2030.
  • The benzalkonium chloride 50% bifurcation, under the type segment of the benzalkonium chloride market, held the larger share in the past.
  • The horticulture & household category is predicted to continue to dominate the benzalkonium chloride market throughout this decade, based on end-use industry.

Liberty Gold Reports Q4 2020 Financial and Operating Results

Retrieved on: 
Friday, March 26, 2021
Chemistry, Physical sciences, Chemical compounds, Chlorides, Gold(I,III) chloride, Loss given default, Au, Au

VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) ("Liberty Gold" or the "Company"), is pleased to announce its financial and operating results for the year ended December 31, 2020.

Key Points: 
  • VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) ("Liberty Gold" or the "Company"), is pleased to announce its financial and operating results for the year ended December 31, 2020.
  • Highlights include6:
    1.98 grams per tonne of gold (g/t Au) over 33.5 m, including 3.93 g/t Au over 15.2 m, and 1.11 g/t Au over 30.5 m in LBP127.
  • 0.98 g/t Au over 80.8 m, including 2.32 g/t Au over 18.3 m and 2.19 g/t Au over 7.6 m in LBP169.
  • 3.62 g/t Au over 8.1 m and 1.27 g/t Au over 54.2 m, including 2.51 g/t Au over 17.0 m in LBP222C.

Worldwide Benzalkonium Chloride Industry to 2030 - Market Analysis and Growth Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, March 26, 2021
Chemicals, Plastics, Manufacturing, Chemical compounds, Cationic surfactants, Quaternary ammonium compounds, Chemistry, Antiseptics, Chlorides, Benzyl compounds, Physical sciences, Benzalkonium chloride, Polyvinyl chloride

The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Benzalkonium Chloride Market Research Report: By Type, Application, End-Use Industry - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global benzalkonium chloride market to $1,301.1 million by 2030 from $525.0 million in 2019, at a 9.6% CAGR between 2020 and 2030.
  • The benzalkonium chloride 50% bifurcation, under the type segment of the benzalkonium chloride market, held the larger share in the past.
  • The horticulture & household category is predicted to continue to dominate the benzalkonium chloride market throughout this decade, based on end-use industry.

The Benzalkonium Chloride Market is projected to exceed $1.28 billion by 2027, Says Global Market Insights Inc.

Retrieved on: 
Monday, March 22, 2021
Biocides, Chemistry, Physical sciences, Bactericides, Antiseptics, Cationic surfactants, Quaternary ammonium compounds, Chlorides, Benzalkonium chloride, Disinfectant, Surfactant, Antimicrobial

Demand for antiseptics, disinfectants, wetting agent, solubilizing agent and antimicrobial preservative is expected to stimulate product demand from pharmaceutical sector.

Key Points: 
  • Demand for antiseptics, disinfectants, wetting agent, solubilizing agent and antimicrobial preservative is expected to stimulate product demand from pharmaceutical sector.
  • Benzalkonium chloride market from 50% concentration type surpassed USD 160 million in 2020 pertaining to its application as germicide and should raise product demand in the projected timespan.
  • The region is expected to witness increased benzalkonium chloride market demand for disinfectant application in agricultural process.
  • Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider.